Cookson Peirce & Co. Inc. Sells 30,267 Shares of Axon Enterprise, Inc $AXON

Cookson Peirce & Co. Inc. lessened its stake in shares of Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 83.3% during the 4th quarter, Holdings Channel reports. The fund owned 6,070 shares of the biotechnology company’s stock after selling 30,267 shares during the period. Cookson Peirce & Co. Inc.’s holdings in Axon Enterprise were worth $3,447,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Brighton Jones LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter worth $480,000. NewEdge Advisors LLC boosted its position in shares of Axon Enterprise by 41.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC boosted its position in shares of Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after purchasing an additional 157 shares in the last quarter. Woodline Partners LP boosted its position in shares of Axon Enterprise by 40.6% in the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after purchasing an additional 2,003 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth $284,000. Institutional investors own 79.08% of the company’s stock.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the sale, the insider owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. The trade was a 3.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Erika Nardini sold 198 shares of Axon Enterprise stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the sale, the director directly owned 1,946 shares of the company’s stock, valued at approximately $985,804.68. This represents a 9.24% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 3,548 shares of company stock worth $1,542,775. 4.20% of the stock is owned by insiders.

Axon Enterprise Stock Performance

Shares of AXON opened at $486.12 on Friday. The stock has a 50-day moving average of $408.04 and a two-hundred day moving average of $491.92. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The stock has a market cap of $39.18 billion, a P/E ratio of 195.23, a P/E/G ratio of 8.84 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter in the previous year, the firm posted $1.47 EPS. The firm’s revenue was up 33.7% compared to the same quarter last year. As a group, research analysts predict that Axon Enterprise, Inc will post 1.82 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on AXON shares. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research report on Thursday, May 7th. UBS Group lowered their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a research report on Thursday, May 7th. Citigroup reissued a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Piper Sandler lowered their price objective on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a research report on Thursday, May 7th. Finally, Royal Bank Of Canada lowered their price objective on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

Read Our Latest Report on Axon Enterprise

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.